The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed: HGCSG 1201/OGSG1205.
 
Yasuyuki Kawamoto
Honoraria - Sawai Pharmaceutical Co
 
Takashi Meguro
No Relationships to Disclose
 
Satoshi Yuki
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
 
Hiroshi Nakatsumi
No Relationships to Disclose
 
Takahide Sasaki
No Relationships to Disclose
 
Kazuteru Hatanaka
No Relationships to Disclose
 
Minoru Uebayashi
No Relationships to Disclose
 
Ichiro Iwanaga
No Relationships to Disclose
 
Nobuhiko Abe
No Relationships to Disclose
 
Michio Nakamura
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo
Research Funding - Astellas Pharma (Inst); Takeda (Inst); Zeria Pharmaceutical (Inst)
 
Hiroyuki Okuda
No Relationships to Disclose
 
Kazunori Eto
No Relationships to Disclose
 
Ayane Oba
No Relationships to Disclose
 
Masakazu Abe
No Relationships to Disclose
 
Koji Oba
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Yuh Sakata
Honoraria - Daiichi Sankyo; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo; Otsuka; Taiho Pharmaceutical
 
Naoya Sakamoto
No Relationships to Disclose
 
Yoshito Komatsu
Honoraria - Bayer; Novartis; Pfizer
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Bayer; Chugai Pharma; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha